CABA · Cabaletta Bio, Inc.
$2.75
-0.08 (-2.83%)
At close · Jul 20
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We have identified conditions that raise substantial doubt about our ability to continue as a going concern. If we are unable to secure additional funding beyond our current cash position that enables our operations into mid-2027, we may be forced to delay, reduce or discontinue our product development programs efforts or other operations.”View the 10-Q filed May 14, 2026
Market Cap
$448.40M
Shares
163.05M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-06-30 | 53,083 | $3.11 | $165,088 |
| 2026-06-29 | 2,158,953 | $3.04 | $6,563,217 |
| 2026-06-25 | 213 | $3.03 | $645 |
| 2026-06-24 | 3,833 | $3.02 | $11,576 |
| 2026-06-23 | 482,798 | $3.01 | $1,453,222 |
| 2026-06-22 | 438,304 | $2.84 | $1,244,783 |
| 2026-06-17 | 7,962 | $2.80 | $22,294 |
| 2026-06-15 | 386 | $3.01 | $1,162 |
| 2026-06-12 | 261,914 | $3.01 | $788,361 |
| 2026-06-04 | 80,314 | $3.58 | $287,524 |
| 2026-06-03 | 26,428 | $3.68 | $97,255 |
| 2026-05-22 | 73,221 | $3.69 | $270,185 |
| 2026-05-21 | 112,763 | $3.44 | $387,905 |
| 2026-05-20 | 8,893 | $3.27 | $29,080 |
| 2026-05-19 | 32,990 | $3.29 | $108,537 |
| 2026-05-18 | 1,130,313 | $3.31 | $3,741,336 |
| 2026-05-13 | 1,100 | $3.63 | $3,993 |
| 2026-05-11 | 500 | $3.88 | $1,940 |
| 2026-05-08 | 43,502 | $4.00 | $174,008 |
| 2026-04-30 | 116,217 | $2.78 | $323,083 |
| 2026-04-29 | 771 | $2.86 | $2,205 |
| 2026-04-24 | 33,314 | $3.05 | $101,608 |
Showing 1–22 of 22 settlements